Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$9.8M
3 rounds on record
Latest round
$5.8M
Venture round · Nov 2024 · 23 mo ago
Grants
$2.9M
1 grant · CORDIS
Backers
1
Initialized Capital
The money's age
Due for its next round
23 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 20, 2024 Board appointment Nicholas Saccomano, Director · SEC Form D Nov 6, 2024 Raised a round Venture round $5.8M · SEC Form D Sep 15, 2023 Won a grant $2.9M · CORDIS Jun 8, 2021 Raised a round Venture round $3.9M · SEC Form D 2021 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Nov 2024 $5.8M — SEC Form D
Grant Sep 2023 $2.9M — CORDIS
Venture round Jun 2021 $3.9M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity MODULO BIO, INC. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Michael HorowitzExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Advancing Accessible Solutions for Complex Neurodegenerative Diseases. Protecting neurons to advance treatment for neurodegenerative…
CND Life SciencesVenture round $8.6M · 19 mo ago • Founded 2017
CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Vanqua BioVenture round $45M · 2 yr ago • Founded 2019 • 201-500 employees
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
VectoryTxFounded 2020 • 51-200 employees • 1 role
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
RetiSpecSeries A $10M · 2 yr ago • 51-200 employees
RetiSpec is a medical imaging company using advanced AI for the detection of neurodegenerative diseases through hyperspectral imaging of…

Overview

Modulo is decoding the neuroimmune system. Applying science and engineering to identify new treatment paths for neurodegenerative diseases.

People

Michael Horowitz
Executive Officer, Director
Nicholas Saccomano
Director
Alda Dennis
Director
Alexander Patterson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego United States
HQ

Financials

Total raised
$12.6M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $5.8M Details
Grant 2023 $2.9M Details
Venture - Series Unknown 2021 $3.9M Details